Agape ATP Corporation (NASDAQ:ATPC) Short Interest Update

Agape ATP Corporation (NASDAQ:ATPC) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 29,079 shares, a growth of 88.6% from the July 15th total of 15,420 shares. Approximately 3.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,579,723 shares, the days-to-cover ratio is presently 0.0 days.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ATPC shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently raised its position in Agape ATP stock. Citadel Advisors LLC grew its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the period. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is owned by hedge funds and other institutional investors.

Agape ATP Stock Performance

Shares of Agape ATP stock opened at $2.52 on Tuesday. Agape ATP has a 52-week low of $1.72 and a 52-week high of $73.50. The company has a fifty day moving average of $2.81 and a 200-day moving average of $2.78. The stock has a market capitalization of $2.52 million, a price-to-earnings ratio of -1.89 and a beta of 0.38.

Agape ATP (NASDAQ:ATPC) last posted its quarterly earnings results on Friday, August 14th. The company reported $0.15 earnings per share (EPS) for the quarter. The business had revenue of $0.01 million for the quarter. Agape ATP had a negative return on equity of 5.38% and a negative net margin of 106.90%.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.